|Tested species reactivity||Human|
|Published species reactivity||Human, Not Applicable|
|Host / Isotype||Mouse / IgG1|
|Storage buffer||ascites diluted in PBS|
|Contains||0.02% sodium azide|
|Storage Conditions||4° C|
|Tested Applications||Dilution *|
|Immunohistochemistry (Frozen) (IHC (F))||1:10 - 1:20|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
In IHC applications, this antibody only works on frozen sections and not on paraffin sections.
Natural killer (NK) cells in teleosts and their evolutionary homologue are a subpopulation of lymphocytes with properties that distinguish them from either B- or T-cells. NK cells are important effectors of innate immunity where they release cytokines, which in turn up-regulate other immunological functions. Monoclonal antibodies have been used to identify different surface antigens present on NK cells. These surface antigens have not only been used to identify NK cells, but also their functionally distinct subsets. The Cluster of Differentiation (CD) nomenclature was established to standardize the naming of NK cells.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
|Not Applicable||Not Cited||
Autologous bone-marrow mononuclear cell transplantation after acute myocardial infarction: comparison of two delivery techniques.
MA1-35251 was used in flow cytometry to assess the safety and feasibility of autologous bone marrow mononuclear cells transplantation in ST elevation myocardial infarction
|Silva SA,Sousa AL,Haddad AF,Azevedo JC,Soares VE,Peixoto CM,Soares AJ,Issa AF,Felipe LR,Branco RV,Addad JA,Moreira RC,Tuche FA,Mesquita CT,Drumond CC,Junior AO,Rochitte CE,Luz JH,Rabischoffisky A,Nogueira FB,Vieira RB,Junior HS,Borojevic R,Dohmann HF||Cell transplantation (18:343)||2009|
|Not Applicable||Not Cited||
Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy.
MA1-35251 was used in flow cytometry to assess the safety and efficacy of autologous bone marrow mononuclear cell injected into areas of ischemic myocardium in patients with end-stage ischemic cardiomyopathy
|Perin EC,Dohmann HF,Borojevic R,Silva SA,Sousa AL,Silva GV,Mesquita CT,Belém L,Vaughn WK,Rangel FO,Assad JA,Carvalho AC,Branco RV,Rossi MI,Dohmann HJ,Willerson JT||Circulation (110:II213)||2004|
Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure.
MA1-35251 was used in flow cytometry to test if transendocardial injections of autologous mononuclear bone marrow cells in patients with end-stage ischemic heart disease promotes neovascularization and improves perfusion and myocardial contractility.
|Perin EC,Dohmann HF,Borojevic R,Silva SA,Sousa AL,Mesquita CT,Rossi MI,Carvalho AC,Dutra HS,Dohmann HJ,Silva GV,Belém L,Vivacqua R,Rangel FO,Esporcatte R,Geng YJ,Vaughn WK,Assad JA,Mesquita ET,Willerson JT||Circulation (107:2294)||2003|
Pre-procedural expression of Mac-1 and LFA-1 on leukocytes for prediction of late restenosis and their possible correlation with advanced coronary artery disease.
MA1-35251 was used in flow cytometry to examine adhesion molecules in patients with restenosis.
|Rahimi K,Maerz HK,Zotz RJ,Tárnok A||Cytometry. Part B, Clinical cytometry (53:63)||2003|
Expression and coreceptor activity of STRL33/Bonzo on primary peripheral blood lymphocytes.
MA1-35251 was used in flow cytometry to characterize the localization and function of STRL33/Bonzo.
|Sharron M,Pöhlmann S,Price K,Lolis E,Tsang M,Kirchhoff F,Doms RW,Lee B||Blood (96:41)||2000|
In vivo description of dendritic cells in human renal cell carcinoma.
MA1-35251 was used in immunohistochemistry to discuss the role of dendritic cells in human renal cell carcinoma.
|Schwaab T,Schned AR,Heaney JA,Cole BF,Atzpodien J,Wittke F,Ernstoff MS||The Journal of urology (162:567)||1999|
Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages.
MA1-35251 was used in flow cytometry to determine the number of CD4, CCR5, and CXCR4 antibody-binding sites on various T cells and macrophages.
|Lee B,Sharron M,Montaner LJ,Weissman D,Doms RW||Proceedings of the National Academy of Sciences of the United States of America (96:5215)||1999|